Pediatrix Medical Group, Inc. (MD)

Over the past six months, Pediatrix Medical Group, Inc. experienced several events impacting its stock price. After reporting Q4 2025 earnings, MD shares declined by -12.2% but later drifted higher by +10.8%. The company expanded its maternal health services in Tennessee and welcomed two new physician leaders. The company announced its 47th Annual NEO conference. As of April 6, 2026, the stock price was $21.69 per share, a 65.07% increase from April 7, 2025.

While specific details on demand seasonality are not explicitly provided, healthcare services, particularly those related to births and pediatric care, can experience some level of seasonality. Factors such as birth rates and seasonal illnesses affecting children could influence demand, and Simply Wall St indicates that it displays mean and median monthly returns for MD to identify seasonal patterns.

Pediatrix Medical Group, Inc. is a leading national medical group specializing in physician services for women, babies, and children across the continuum of care, in both hospital and office-based settings. The company operates in the Health Services sector, primarily in Medical/Nursing Services, and also includes Other Healthcare Services, Hospitals/Inpatient Services, and Practice Management (Healthcare). Its major products and services include neonatal care, maternal-fetal care, obstetrics and gynecology, pediatric subspecialties, and a newborn hearing screening program.

Pediatrix Medical Group, Inc. has a significant national presence across the United States, treating patients in 42 states and territories and billing for services in 37 states and Puerto Rico. As of January 2023, Pediatrix had over 1,190 locations, 2,780+ physicians, and 290+ practices, including managing clinical activities at more than 360 NICUs.

Pediatrix Medical Group has a strong reputation and brand recognition, particularly in providing critical high-risk obstetrical and neonatology services. The company emphasizes high-quality, evidence-based care and actively invests in research, education, quality-improvement, and safety initiatives. A significant event impacting its brand was the rebrand from MEDNAX, Inc. to Pediatrix Medical Group, Inc. in July 2022, underscoring its focus on care for women, babies, and children.

The ownership structure of Pediatrix Medical Group (MD) stock is predominantly institutional, with approximately 81.61% owned by Institutional Investors, 1.28% by Insiders, and 17.11% by Public Companies and Individual Investors. Major institutional owners include BlackRock, Inc., Vanguard Group Inc., and Victory Capital Management Inc., among others.